Thrombolytic therapy with intravenous streptokinase has been shown to improve survival after acute myocardial infarction. 1.2 However, patients who have suspected infarction at the time of an operation would not generally be considered for streptokinase therapy because of their increased risk of surgical bleeding. We present a case of acute myocardial infarction following minor laryngeal surgery under general anaesthesia that was successfully treated with streptokinase.
CASE REPORT
A 65-year-old Polish woman was scheduled for laryngoscopy and possible laryngeal biopsy. Ten months earlier, a TzN o squamous cell carcinoma of the right vocal cord was diagnosed. The patient refused surgery and was treated with radiotherapy. Five months later, she developed progressive upper airway obstruction necessitating a tracheostomy. Two months later, laryngoscopy and biopsy performed under general anaesthesia were negative for tumour and the provisional diagnosis was radionecrosis of the laryngeal cartilages. Immediately prior to the current admission, she experienced throat pain and repeat laryngoscopy was scheduled.
Her only other medical problem was degenerative joint disease and her medications were paracetamol and diflunisal. She had stopped smoking three years earlier. Her mother and sister had heart disease. She spoke minimal English.
On the evening before the procedure, preoperative examination was unremarkable except for the presence of a tracheostomy and obesity. A routine 12-lead electrocardiogram (ECG) was unremarkable. The anaesthetic plan was discussed with her daughter acting as interpreter. An inhalation induction using a tracheostomy tube was discussed. This technique had been used on a previous occasion by this same anaesthetist. The patient agreed to this technique and oral premedication (temazepam 20 mg, metoc!opramide 10 mg) was prescribed.
On the day of surgery, there was a three-hour delay between receiving the premedication and induction of anaesthesia. She arrived in the anaesthetic room crying. After a brief period of reassurance, the tracheal mucosa was sprayed with lignocaine spray via the tracheostomy and a cuffed tracheostomy tube was placed easily. Induction of anaesthesia was achieved with the patient breathing isoflurane and nitrous oxide in oxygen. Laryngoscopy was performed and three superficial biopsies were taken from the right arytenoid area. Operative bleeding was minimal and no haemostatic measures were required. No muscle relaxant was used and there was one episode of some patient movement ("bucking") controlled by deepening of anaesthesia with propofol 50 mg IV. During the IS-minute procedure the systolic blood pressure ranged between 105 and 150 mmHg and the heart rate ranged between 100 and 115 beats/min. The heart rhythm was sinus and oxygen saturation remained at 98070.
On arrival in the recovery room, the patient was breathing spontaneously and received oxygen via tracheostomy mask. The cuffed tracheostomy tube remained in place. The blood pressure and heart rate were normal. Normal sinus rhythm was seen on a threelead monitor. Upon awakening, the patient appeared distressed and an interpreter was summoned. The patient described new central chest pain. Papaveretum 2.5 mg was given intravenously with little effect. Sublingual nitroglycerine 0.6 mg and sublingual nifedipine 10 mg were also given with mild effect. A 12-lead ECG revealed no change from the preoperative one. The pain abated for a short period but had returned to initial levels 30 minutes later. A second ECG was performed and ST-segment elevation was seen in leads 11, III and aVE Urgent cardiological opinion was requested. No bleeding was noted at this time.
Following review by a cardiologist, the ENT surgical team was contacted to discuss the potential problems of streptokinase therapy following tissue biopsy. With approval from the ENT surgeon, aspirin 300 mg was given orally and an intravenous infusion of streptokinase (Streptase, Behring) 1,500,000 IU was given over 30 minutes and she was transferred to the Coronary Care Unit (CCU).
On arrival in the CCU the blood pressure and heart rate were normal. Repeat ECG showed resolution of the ST-segment changes. Atenolol 10 mg was given IV. Recurrence of chest pain was treated with an intravenous nitroglycerine infusion and small doses of intravenous morphine. Bleeding was minimal and was easily managed by frequent suctioning of the tracheostomy tube. After two days all bleeding had stopped. The blood pressure and heart rate and rhythm remained normal and she was discharged from CCU to the ward. There was no significant fall in haemoglobin concentration. The laryngeal biopsies showed no tumour.
Twelve days later another episode of chest pain was reported and urgent coronary angiography was performed. The left ventriculogram was normal but complete occlusion of the right coronary artery was seen. All other coronary vessels appeared normal. A right coronary angioplasty was performed successfully and recovery was uneventful. At follow-up two years later the patient remains free from chest pain.
DISCUSSION
The occurrence of perioperative myocardial ischaemia is of great concern to anaesthetists and surgeons. J The patient in this report had significant occult coronary artery disease and the stresses of anaesthesia and minor surgery may have induced cardiac ischaemia. Further, the lengthy delay in the surgical start time was apparent to this patient and resulted in considerable distress to her. There is some evidence that psychological stress may induce myocardial ischaemia. 4.5 The brief period of raised blood pressure (150 mmHg) and increased heart rate (115 beats/min) associated with patient movement and possibly an inadequate depth of anaesthesia, may have precipitated ischaemia. While routine 3-lead ECG monitoring revealed no sign of ischaemia, this technique is notoriously unreliable. However, chest pain in postoperative patients is a serious symptom and aroused the suspicion of acute cardiac disease. Despite an initial ECG that was normal, coronary vasodilators and an opioid were given. A subsequent ECG was diagnostic and treatment options for acute myocardial infarction were considered urgently.
Perioperative mortality from acute myocardial infarction can be significantly reduced by the use of thrombolytic therapy such as streptokinase. The mortality from acute myocardial infarction is shown to be reduced at 21 days. 1 It is believed that the mechanism of this reduction of mortality is the reperfusion of jeopardized myocardium and timing of the therapy is all important in optimizing the outcome. Further, ramdomised trials of thrombolytic therapy have been shown to preserve left ventricular function in patients with acute myocardial infarction who have developed ST-segment elevation. 1.2 However, this therapy is not without significant risks and one of the main complications is excessive bleeding. In particular, this risk is increased in traumatised areas including arterial puncture sites or surgical wounds. In the presence of the latter, the risk of bleeding is considered to be so excessive that streptokinase is usually contraindicated as mortality from the complication may be greater than that of the infarction. For this reason, management of acute myocardial infarction in the postoperative period is frequently limited to less efficacious treatments and supportive therapy. Emergency coronary angiography is not consistently performed in the acute phase of infarction as the mortality from the ensuing intervention is also increased. Emergency coronary bypass surgery is frequently considered too risky, especially when previous surgery has just been performed and anticoagulation is required. This case raises several questions. First, is the reduction in mortality from thrombolytic therapy exceeded by increased mortality from the complication of haemorrhage? Secondly, would the overall outlook be improved, in the possible presence of recurrent laryngeal carcinoma, by the treatment of an inferior acute myocardial infarction? These points were considered in making the decision to aggressively treat this patient. If streptokinase therapy was to be used, the site of the surgery would almost certainly be the site of any bleeding. While laryngeal bleeding could be life-threatening in most adults, it should be more easily recognised and managed in the presence of a tracheostomy. We also recognised that the mortality from acute myocardial infarction is the greatest in the first three days-the period when bleeding is most likely to occur in postoperative patients treated with streptokinase. A final consideration was that the life expectancy from treated carcinoma of the larynx would be greater than that of an untreated acute myocardial infarction.
Fortunately, this patient already had a trachestomy. The bleeding that did occur originated from an area above the cuffed tracheostomy tube, thus reducing the chances of pulmonary aspiration of blood. Also, the amount of bleeding was less than expected. The subsequent resolution of ECG changes implied that there had been salvage of myocardium. No other complications from the ischaemic event were seen. To our knowledge, this is the first report of successful streptokinase therapy immediately following minor surgery.
In conclusion, thrombolytic therapy after relatively minor surgery may be considered in patients where acute myocardial infarction is strongly suspected when the potential benefit of myocardial salvage outweighs the likely complication of major haemorrhage.
Shivering occurring after general or regional anaesthesia is very common but the aetiology remains unclear. Most of the perioperative shivering is relatively benign, but it can be dangerous in patients with limited cardiovascular and respiratory function because of the associated adverse metabolic and haemodynamic sequelae. 1, 2 Occasionally, perioperative shivering is a manifestation of an underlying disease,' which must be differentiated from the usual post-anaesthetic shivering. A case of postoperative hypoglycaemiainduced shivering, which was initially misdiagnosed as septicaemic shock, is reported.
CASE REPORT
A 66-year-old man weighing 60 kg was booked for percutaneous ultrasonic nephrolithotripsy. Past medical history showed a seven-year history of diabetes mellitus treated with glibenclamide. There was no history of alcohol abuse, hypoglycaemic attacks, liver or renal
